Sumera Perveen

581 total citations
16 papers, 255 citations indexed

About

Sumera Perveen is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Sumera Perveen has authored 16 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in Sumera Perveen's work include SARS-CoV-2 and COVID-19 Research (5 papers), RNA and protein synthesis mechanisms (4 papers) and Biochemical and Molecular Research (3 papers). Sumera Perveen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), RNA and protein synthesis mechanisms (4 papers) and Biochemical and Molecular Research (3 papers). Sumera Perveen collaborates with scholars based in Canada, United States and Pakistan. Sumera Perveen's co-authors include Masoud Vedadi, Kanchan Devkota, Fengling Li, Aliakbar Khalili Yazdi, Taraneh Hajian, Irene Chau, Pegah Ghiabi, Albina Bolotokova, Naeem Rashid and Evžen Bouřa and has published in prestigious journals such as Biochemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Sumera Perveen

16 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumera Perveen Canada 9 169 94 43 23 22 16 255
Taniya Bhardwaj India 10 136 0.8× 128 1.4× 35 0.8× 27 1.2× 9 0.4× 18 273
Albina Bolotokova Canada 9 122 0.7× 68 0.7× 38 0.9× 21 0.9× 13 0.6× 11 192
Kanchan Devkota Denmark 6 163 1.0× 74 0.8× 30 0.7× 15 0.7× 14 0.6× 13 227
Christophe Buyck Belgium 8 157 0.9× 136 1.4× 81 1.9× 29 1.3× 25 1.1× 15 356
Eva Konkoľová Czechia 9 107 0.6× 113 1.2× 24 0.6× 14 0.6× 16 0.7× 15 264
Darren W. Begley United States 11 234 1.4× 43 0.5× 32 0.7× 15 0.7× 20 0.9× 19 290
Karoline Leopold Canada 7 195 1.2× 237 2.5× 51 1.2× 32 1.4× 14 0.6× 7 419
Victoria C. Yan United States 8 90 0.5× 133 1.4× 29 0.7× 7 0.3× 30 1.4× 18 272
Laura M. Deveau United States 6 199 1.2× 96 1.0× 32 0.7× 14 0.6× 7 0.3× 9 372
Mohamed Mahdi Hungary 7 96 0.6× 124 1.3× 76 1.8× 23 1.0× 10 0.5× 26 264

Countries citing papers authored by Sumera Perveen

Since Specialization
Citations

This map shows the geographic impact of Sumera Perveen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumera Perveen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumera Perveen more than expected).

Fields of papers citing papers by Sumera Perveen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumera Perveen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumera Perveen. The network helps show where Sumera Perveen may publish in the future.

Co-authorship network of co-authors of Sumera Perveen

This figure shows the co-authorship network connecting the top 25 collaborators of Sumera Perveen. A scholar is included among the top collaborators of Sumera Perveen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumera Perveen. Sumera Perveen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Perveen, Sumera, Aliakbar Khalili Yazdi, Taraneh Hajian, Fengling Li, & Masoud Vedadi. (2024). Kinetic characterization of human mRNA guanine-N7 methyltransferase. Scientific Reports. 14(1). 4509–4509. 2 indexed citations
2.
Eguida, Merveille, Guillaume Bret, Fengling Li, et al.. (2024). Subpocket Similarity-Based Hit Identification for Challenging Targets: Application to the WDR Domain of LRRK2. Journal of Chemical Information and Modeling. 64(13). 5344–5355. 4 indexed citations
3.
Hossain, Mohammad Anwar, Peter J. Brown, Meganathan Nandakumar, et al.. (2024). Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of Chikungunya nsP2 Cysteine Protease with Antialphavirus Activity. Journal of Medicinal Chemistry. 67(18). 16505–16532. 5 indexed citations
4.
Ahmad, Shabbir, Mark Mabanglo, Levon Halabelian, et al.. (2024). Development of Peptide Displacement Assays to Screen for Antagonists of DDB1 Interactions. Biochemistry. 63(10). 1297–1306. 2 indexed citations
5.
Zong, Yu, et al.. (2024). Development of Complementary Photo‐arginine/lysine to Promote Discovery of Arg/Lys hPTMs Interactomes. Advanced Science. 11(14). e2307526–e2307526. 4 indexed citations
6.
Kimani, Serah, Sumera Perveen, Hong Zeng, et al.. (2023). The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition. Communications Biology. 6(1). 1272–1272. 12 indexed citations
7.
Li, Fengling, Pegah Ghiabi, Taraneh Hajian, et al.. (2023). SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(4). 130319–130319. 15 indexed citations
8.
Yazdi, Aliakbar Khalili, Sumera Perveen, Taraneh Hajian, et al.. (2022). Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infectious Diseases. 8(8). 1533–1542. 14 indexed citations
9.
Devkota, Kanchan, Matthieu Schapira, Sumera Perveen, et al.. (2021). Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors. SLAS DISCOVERY. 26(9). 1200–1211. 55 indexed citations
10.
Yazdi, Aliakbar Khalili, Fengling Li, Kanchan Devkota, et al.. (2021). A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex. SLAS DISCOVERY. 26(6). 757–765. 18 indexed citations
11.
Perveen, Sumera, Aliakbar Khalili Yazdi, Kanchan Devkota, et al.. (2021). A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19. SLAS DISCOVERY. 26(5). 620–627. 22 indexed citations
12.
Šála, Michal, Fengling Li, Jindřich Fanfrlík, et al.. (2021). The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors. ACS Infectious Diseases. 7(8). 2214–2220. 69 indexed citations
13.
Rashid, Naeem, et al.. (2018). Extremely stable indole-3-glycerol-phosphate synthase from hyperthermophilic archaeon Pyrococcus furiosus. Extremophiles. 23(1). 69–77. 8 indexed citations
14.
Perveen, Sumera, Naeem Rashid, Xiaofeng Tang, Tadayuki Imanaka, & Anastassios C. Papageorgiou. (2017). Anthranilate phosphoribosyltransferase from the hyperthermophilic archaeon Thermococcus kodakarensis shows maximum activity with zinc and forms a unique dimeric structure. FEBS Open Bio. 7(8). 1217–1230. 14 indexed citations
15.
Perveen, Sumera, et al.. (2016). Pcal_1127, a highly stable and efficient ribose-5-phosphate pyrophosphokinase from Pyrobaculum calidifontis. Extremophiles. 20(6). 821–830. 8 indexed citations
16.
Perveen, Sumera, Naeem Rashid, & Anastassios C. Papageorgiou. (2016). Crystal structure of a phosphoribosyl anthranilate isomerase from the hyperthermophilic archaeonThermococcus kodakaraensis. Acta Crystallographica Section F Structural Biology Communications. 72(11). 804–812. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026